First Time Loading...
N

NeoPharm Co Ltd
KOSDAQ:092730

Watchlist Manager
NeoPharm Co Ltd
KOSDAQ:092730
Watchlist
Price: 28 400 KRW 3.27% Market Closed
Updated: May 28, 2024

NeoPharm Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NeoPharm Co Ltd
Revenue Peer Comparison

Comparables:
090430
002790
192820
051900
161890

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
N
NeoPharm Co Ltd
KOSDAQ:092730
Revenue
₩101.7B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
17%
AmorePacific Corp
KRX:090430
Revenue
₩3.7T
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
1%
Amorepacific Group
KRX:002790
Revenue
₩4T
CAGR 3-Years
-7%
CAGR 5-Years
-8%
CAGR 10-Years
0%
Cosmax Inc
KRX:192820
Revenue
₩1.8T
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
N/A
LG H&H Co Ltd
KRX:051900
Revenue
₩6.8T
CAGR 3-Years
-5%
CAGR 5-Years
0%
CAGR 10-Years
5%
Kolmar Korea Co Ltd
KRX:161890
Revenue
₩2.2T
CAGR 3-Years
18%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is NeoPharm Co Ltd's Revenue?
Revenue
101.7B KRW

Based on the financial report for Mar 31, 2024, NeoPharm Co Ltd's Revenue amounts to 101.7B KRW.

What is NeoPharm Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
17%

Over the last year, the Revenue growth was 18%. The average annual Revenue growth rates for NeoPharm Co Ltd have been 6% over the past three years , 8% over the past five years , and 17% over the past ten years .